Is compounded tirzepatide still available anywhere legitimate?

Short answer: No — you should not rely on compounded tirzepatide as a legitimate or safe option for treatment. Because FDA‑approved versions of tirzepatide (Eli Lilly’s Mounjaro for diabetes and Zepbound for weight management) are commercially available, compounding pharmacies generally should not be making copycat tirzepatide for patient use and doing so raises legal and safety concerns.

Why:

• Federal and state rules limit compounding of drugs when an FDA‑approved product exists. Compounding an approved drug is only permitted in narrow, patient‑specific circumstances.
• Peptides like tirzepatide require sterile, GMP‑level manufacturing. Compounded product from unknown online sources has documented risks (wrong dose, contamination, improper storage).
• The FDA and state boards have issued warnings about unsafe compounded “GLP‑1”/peptide products sold online.

Where people sometimes see it offered (and why those are risky):

• Some research‑only peptide suppliers or overseas vendors sell “tirzepatide” for lab use — not legal or safe for human injections.
• A few compounding pharmacies or clinics may advertise peptide compounding, but reputable 503A/503B facilities will avoid compounding copies of marketed, approved drugs except in very limited, lawful situations.

What to do instead:

• Talk with a licensed clinician about a prescription for the approved products (Mounjaro or Zepbound) — these come from regulated manufacturers and specialty pharmacies.
• If cost or access is the issue, ask about manufacturer assistance programs (Eli Lilly has patient support programs and savings offers), insurance prior‑authorization help, and discount services such as GoodRx or assistance from specialty pharmacies (examples: CVS Specialty, Accredo, Optum Rx).
• If you ever consider a compound, only use a pharmacy accredited by recognized bodies (PCAB accreditation) and check your state board of pharmacy; but expect legitimate pharmacies to decline compounding tirzepatide because of regulatory and safety reasons.

If you want, tell me your country and whether cost/insurance or supply is the problem — I can suggest specific, legitimate routes (patient assistance programs, specialty pharmacies, or telehealth services) to get FDA‑approved tirzepatide safely.